地中海饮食依从性与晚期年龄相关性黄斑变性进展:AREDS与AREDS2分析
结果显示,地中海饮食评分最高三分位与最低三分位相比,晚期AMD进展风险降低(HR 0.78),地图样萎缩风险降低更明显(HR 0.71),新生血管性AMD风险亦降低(HR 0.84)。鱼类摄入与晚期AMD风险降低相关,且CFH基因型影响该关联。
要点
- 地中海饮食依从性越高,晚期AMD及大玻璃膜疣进展风险越低。
- 对地图样萎缩的保护信号强于新生血管性AMD。
- CFH基因型显著影响地中海饮食及鱼类摄入与晚期AMD的关联。
核心结论
- 更严格遵循地中海饮食与晚期AMD及大玻璃膜疣进展风险降低相关。
- 该保护关联在地图样萎缩中比新生血管性AMD更明显,鱼类摄入有贡献,且受CFH基因型影响。
研究设计与样本
- 回顾性分析两个对照临床试验队列:AREDS和AREDS2。
- 通过食物频率问卷计算改良替代地中海饮食指数(aMedi)评分,每年采集彩色眼底照片并中心判读晚期AMD。
主要发现
- aMedi第三三分位 versus 第一三分位,晚期AMD的HR为0.78(95%CI 0.71-0.85,P<0.0001)。
- 地图样萎缩的HR为0.71(95%CI 0.63-0.80,P<0.0001),新生血管性AMD的HR为0.84(95%CI 0.75-0.95,P=0.005)。
- 鱼类摄入第四四分位 versus 第一四分位,晚期AMD的HR在AREDS为0.69(95%CI 0.58-0.82,P<0.0001),在AREDS2为0.92(95%CI 0.78-1.07,P=0.28)。
- 在AREDS中,aMedi及鱼类成分与CFH rs10922109交互作用显著(P=0.01和P=0.0005),仅在携带保护等位基因者中高aMedi和高鱼类摄入与风险降低相关。
临床怎么用
- 可将地中海饮食模式作为循证饮食建议用于AMD患者咨询,尤其针对地图样萎缩风险人群。
- 鱼类摄入可能有益,但需考虑CFH基因型对关联的影响。
局限性
- 回顾性分析设计。
- 鱼类摄入与晚期AMD的关联在AREDS2中未达统计学显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine whether closer adherence to a Mediterranean diet (and its individual components) was associated with altered risk of progression to late age-related macular degeneration (AMD) and large drusen. Additional objectives were to assess interactions with AMD genotype. DESIGN: Retrospective analysis of 2 controlled clinical trial cohorts: Age-Related Eye Disease Study (AREDS) and AREDS2. PARTICIPANTS: Eyes with no late AMD at baseline in AREDS participants (n = 4255) and AREDS2 participants (n = 3611): total of 13 204 eyes (7756 participants). Mean age was 71 years (standard deviation, 6.6); 56.5% were female. METHODS: Color fundus photographs were collected at annual study visits and graded centrally for late AMD. The modified Alternative Mediterranean Diet Index (aMedi) score was calculated for each participant from food frequency questionnaires. MAIN OUTCOME MEASURES: Progression to late AMD, geographic atrophy (GA), and neovascular AMD; progression to large drusen. RESULTS: Over a median follow-up of 10.2 years, of the 13 204 eyes, 34.0% progressed to late AMD. Hazard ratios (HRs) for progression in aMedi tertile 3 versus 1 were 0.78 (95% confidence interval [CI], 0.71-0.85, P < 0.0001) for late AMD, 0.71 (0.63-0.80, P < 0.0001) for GA, and 0.84 (0.75-0.95, P = 0.005) for neovascular AMD. For fish consumption, HRs for late AMD in quartile 4 versus 1 were 0.69 (0.58-0.82, P < 0.0001; AREDS) and 0.92 (0.78-1.07, P = 0.28; AREDS2). In AREDS, both aMedi and its fish component interacted with CFH rs10922109 for late AMD (P = 0.01 and P = 0.0005, respectively); higher aMedi and fish intake were each associated with decreased risk only in participants with protective alleles. In separate analyses (n = 5029 eyes of 3026 AREDS participants), the HR for progression to large drusen in aMedi tertile 3 versus 1 was 0.79 (0.68-0.93, P = 0.004). CONCLUSIONS: Closer adherence to a Mediterranean-type diet was associated with lower risk of progression to late AMD and to large drusen. The signal was greater for GA than neovascular AMD. Fish intake contributed to this protective association. CFH genotype strongly influenced these relationships. These findings may help inform evidence-based dietary recommendations.
引用
- Keenan TD, Agrón E, Mares J, et al. Adherence to the Mediterranean Diet and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2. Ophthalmology. 2020. PMID: 32348832. doi:10.1016/j.ophtha.2020.04.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。